“Patients With Atopic Dermatitis Using Oral Contraceptive Pills or Hormone Replacement Therapy: Long-Term Safety of Upadacitinib for Major Adverse Cardiovascular Events, Venous Thromboembolism, or Malignancy (Excluding Nonmelanoma Skin Cancer)”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s613, https://doi.org/10.25251/stfagt72.